225 related articles for article (PubMed ID: 30312362)
21. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort.
Chotiprasitsakul D; Han JH; Cosgrove SE; Harris AD; Lautenbach E; Conley AT; Tolomeo P; Wise J; Tamma PD;
Clin Infect Dis; 2018 Jan; 66(2):172-177. PubMed ID: 29190320
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Gudiol C; Royo-Cebrecos C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Tebe C; Carratalà J;
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584145
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.
Hammer KL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):87-91. PubMed ID: 27810318
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
[TBL] [Abstract][Full Text] [Related]
25. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
[TBL] [Abstract][Full Text] [Related]
26. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
[TBL] [Abstract][Full Text] [Related]
27. Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
Berkowitz NM; Spaeder MC; DeBiasi RL; Campos J; Singh N
Pediatr Infect Dis J; 2015 Nov; 34(11):1203-6. PubMed ID: 26301498
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
29. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
Li C; Li Y; Zhao Z; Liu Q; Li B
J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
[TBL] [Abstract][Full Text] [Related]
30. In
Ouranos K; Mylonakis E
Ann Intern Med; 2024 May; 177(5):JC52. PubMed ID: 38710092
[TBL] [Abstract][Full Text] [Related]
31. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
32. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.
Tamma PD; Conley AT; Cosgrove SE; Harris AD; Lautenbach E; Amoah J; Avdic E; Tolomeo P; Wise J; Subudhi S; Han JH;
JAMA Intern Med; 2019 Mar; 179(3):316-323. PubMed ID: 30667477
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
Syue LS; Tang HJ; Hung YP; Chen PL; Li CW; Li MC; Tsai PF; Liu CC; Lee NY; Ko WC
J Microbiol Immunol Infect; 2019 Apr; 52(2):225-232. PubMed ID: 30528336
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).
Gudiol C; Royo-Cebrecos C; Tebe C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Carratalà J;
BMJ Open; 2017 Jan; 7(1):e013268. PubMed ID: 28115333
[TBL] [Abstract][Full Text] [Related]
35. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Russo A; Falcone M; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Cisneros JM; Hernández-Torres A; Farcomeni A; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Mora-Rillo M; Rodriguez-Gomez J; Souli M; Bonomo RA; Paterson DL; Carmeli Y; Pascual A; Rodríguez-Baño J; Venditti M;
Int J Antimicrob Agents; 2018 Nov; 52(5):577-585. PubMed ID: 29969692
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.
Kutob LF; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Int J Antimicrob Agents; 2016 Nov; 48(5):498-503. PubMed ID: 27590704
[TBL] [Abstract][Full Text] [Related]
37. Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study.
Hogan CA; Ebunji B; Watz N; Kapphahn K; Rigdon J; Mui E; Meng L; Alegria W; Holubar M; Deresinski S; Banaei N
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434782
[TBL] [Abstract][Full Text] [Related]
38. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
[TBL] [Abstract][Full Text] [Related]
39. Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Su J; Guo Q; Li Y; Wu S; Hu F; Xu S; Wang M
J Antimicrob Chemother; 2018 Nov; 73(11):3176-3180. PubMed ID: 30099554
[TBL] [Abstract][Full Text] [Related]
40. Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
Chaubey VP; Pitout JD; Dalton B; Gregson DB; Ross T; Laupland KB
BMC Infect Dis; 2014 Dec; 14():647. PubMed ID: 25494640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
